Pharmacogenetic guidance: individualized medicine promotes enhanced pain outcomes
نویسندگان
چکیده
منابع مشابه
Pharmacogenetic guidance: individualized medicine promotes enhanced pain outcomes
The use of pharmacogenomics has become more prevalent over the past several years in treating many disease states. Several cytochrome P450 enzymes play a role in the metabolism of many pain medications including opioids and antidepressants. Noncytochrome P450 enzymes such as methylenetetrahydrofolate reductase (MTHFR) and catechol-O-methyl transferase (COMT) also play a role in the explanation ...
متن کاملIndividualized medicine 2010
Molecular and cell biology have revolutionized not only diagnosis, therapy and prevention of human diseases but also greatly contributed to the understanding of their pathogenesis. Based on modern molecular and biochemical methods it is possible to identify on the one hand point mutations and single nucleotide polymorphisms. On the other hand, using high throughput array technologies, it is pos...
متن کاملOutcomes in Pain Medicine: A Brief Review
Pain, and particularly chronic pain, is a difficult outcome to measure due to its subjective and multidimensional nature. The Institute of Medicine estimates that 100 million Americans have chronic pain with a cost exceeding half a trillion dollars per year. There is a pressing need to identify appropriate outcome measures to better select and evaluate treatment modalities for these patients. I...
متن کاملGenetic variation and individualized medicine.
Mansell is with the Health, Physical Education, and Recreation Dept, Lincoln University, Lincoln University, PA. Tierney is with the Dept of Kinesiology, and Krynetskiy and Mishra, the School of Pharmacy, Temple University, Philadelphia, PA. Driban is with the Division of Rheumatology, Tufts Medical Center, Boston, MA. Clegg is with the Dept of Athletics, George Washington University, Washingto...
متن کاملPharmacogenetics, pharmacogenomics, and individualized medicine.
Individual variability in drug efficacy and drug safety is a major challenge in current clinical practice, drug development, and drug regulation. For more than 5 decades, studies of pharmacogenetics have provided ample examples of causal relations between genotypes and drug response to account for phenotypic variations of clinical importance in drug therapy. The convergence of pharmacogenetics ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Pain Research
سال: 2017
ISSN: 1178-7090
DOI: 10.2147/jpr.s144560